Selvita stock: Selvita registered a statute change. The corporate step concerns Selvita stock

Published on 10/24/2026 at 02:31 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Court registration on October 2, 2026 updated activity codes under PKD 2025. For Selvita stock, a 100 percent-owned-unit merger plan leaves reporting unchanged.

Corporate structure and market context

On October 2, 2026, Selvita registered an articles-of-association amendment tied to PKD 2025.
The September 30, 2026 merger plan covers two wholly owned subsidiaries and issues no new shares.
Selvita stock was last quoted at PLN 17.60 on October 23, 2026, with a PLN 323.0 million market value.

Selvita, PLSLVCR00029, Illustration mit AI erstellt.

Selvita (ISIN PLSLVCR00029) registered an articles-of-association change on October 2, 2026, updating its activity codes under the PKD 2025 classification, according to Parkiet. The filing is the latest dated corporate step in a month that also brought a plan to merge two wholly owned subsidiaries.

Merger plan targets simpler operations

On September 30, 2026, Selvita Services and PozLab agreed and signed a merger plan. Selvita owns 100 percent of both entities, and the simplified transaction will issue no new shares, according to Bankier.pl. The stated objective is to simplify the group structure, streamline internal processes and reduce costs linked to running two entities in parallel.

Three dates shape the plan

On June 24, 2026, Selvita adopted Resolution No. 22, which provided the basis for the later articles amendment, Parkiet reported. On September 30, 2026, the two subsidiaries signed the merger plan. On October 2, 2026, Selvita reported that the court had registered the related statute amendment.

What changes in the accounts?

The merger has a limited direct accounting effect because both subsidiaries are already fully consolidated. The company said the transaction will not change Selvita's consolidated financial statements, while the core business profile and PozLab's existing location will continue under the plan, according to Bankier.pl. Selvita describes its business as an integrated service provider supporting drug discovery and drug development through scientific and technical services, according to Selvita.

Market context for Selvita

A market profile identifies Selvita as SLV.WA on the Warsaw Stock Exchange and assigns the company the submitted ISIN, according to Global Banking and Finance. On GPW, Selvita was last quoted at PLN 17.60 on October 23, 2026 at 4:59 p.m. CEST; its market value was PLN 323.0 million and its 52-week range was PLN 17.52 to PLN 49.40.

The further course of trading is shown by the continuously updated real-time quote of Selvita stock.